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Abstract
Purpose: To evaluate bone blood flow and bone formation in patients after total hip revision
surgery with impacted bone grafting using H2
15O and [18F]fluoride positron emission tomography
(PET).
Procedures: To asses bone blood flow and bone metabolism in bone allograft after impaction
grafting, four patients treated with total hip revision surgery were enrolled prospectively in this
study. Six patients scheduled for primary hip arthroplasties were included as a control group.
The study protocol consisted of three H2
15O and [18F]fluoride PET scans in each patient.
Results: Bone blood flow increased significantly compared to the preoperative state in patients
treated for primary hip arthroplasty. In patients undergoing revision surgery, bone blood flow was
twofold to threefold higher compared to the preoperative state, but did not reach significance.
Bone metabolism in patients undergoing revision was threefold higher 2 weeks postoperatively
compared to the primary hip group. We found a significant correlation between Ki and bone
blood flow.
Conclusions: Allogeneic bone grafts induce a higher rate of local periprosthetic bone formation
compared to periprosthetic bone formation after a primary total hip placement. In vivo coupling
between bone blood flow and bone metabolism suggests that bone metabolism in allogeneic
bone grafts may partly rely on bone blood flow adaptations.
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Introduction
Despite improved surgical techniques and prostheticmaterials, reported failure rates of primary cemented
and uncemented total hip prostheses are significant, varying
between 7% and 17% [1]. As a result of a loosened prosthesis,
acetabular and femoral bone deficiencies may occur because of
mechanical wear and osteolysis. During revision surgery, these
bone deficiencies may be treated with impacted allografts
[2, 3]. Various studies suggest that the results of these oper-
ations are encouraging, whereas some authors report survival
rates up to 100% after 10.4 years (mean) follow-up [4].
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At present, the rate of success is measured by clinical
outcome. In practice, routine x-rays at regular intervals after
surgery are compared with previous films for signs of bone
ingrowth, trabecularization, and cortical remodeling. It is
difficult, however, to detect new bone formation (e.g.,
trabecularization, cortical remodeling) on radiographs and
sometimes it is impossible because of metal meshes used for
the reconstruction of segmental defects. An alternative is
bone scintigraphy, which is useful in assessing loosening,
fracture unions, and bone graft incorporation, but which is
limited in anatomical precision and accuracy [5]. As both
bone blood flow and mineralization of newly formed bone
matrix play a crucial role in bone formation and bone graft
remodeling, positron emission tomography (PET) may
provide a solution since this technique offers a way to
assess regional tissue (patho)physiology with a higher
resolution than that of bone scintigraphy. In addition, PET
allows for the quantification of blood flow and [18F] fluoride
ions and thus can be used to study bone formation directly
[6–9]. In the process of bone regeneration, osteoblasts
produce bone matrix, which is mineralized after an interval
of some days. Fluoride ions exchange with hydroxyl groups
in the hydroxyapatite crystal of bone (Ca10(PO4)6OH2),
which is formed by osteoblasts in the process of minerali-
zation, resulting in fluoroapatite (Ca10(PO4)6F2) [6, 10].
With a better understanding of the biological response of
the morselized bone allografts used during surgery, PET
may provide a new technique to predict the clinical outcome
of the patient. Therefore, the aim of the present study was to
evaluate bone blood flow and new bone formation in
patients after total hip revision surgery with impacted bone
grafting using H2
15O and 18F− PET. In addition, to
understand better the biological effect of bone allografts
used in revision surgery, these results were compared with
those in patients after primary cemented total hip arthro-
plasty in an attempt to discriminate between the effects of
the surgical procedure and those of bone grafting.
Materials and Methods
Study Design
Six patients scheduled for primary hip arthroplasties (group A: six
females; mean age 76±4) and four patients treated with total hip
revision surgery (group B: two males, two females; mean age 76±5)
using impacted bone allografts were enrolled prospectively to
quantitatively assess the process of bone graft remodeling and new
bone formation. The diagnosis for all six primary total hip arthro-
plasties was primary arthrosis. The indication for all four acetabular
and three femoral component revisions was aseptic loosening. In all
patients, cemented total hip prostheses were used. The study was
approved by the medical ethics committee of the VU University
Medical Centre (VUmc). All patients gave written informed consent
after being fully informed about the purpose of the study and any
potential risks. The study protocol consisted of three repeat H2
15O and
18F− PET scans in each patient performed at approximately 1 day
before operation and at 2 and 12 weeks postoperatively.
Surgical Procedure
In all patients, a cemented Exeter™ (Howmedica, London, UK) total
hip prosthesis in a posterolateral approach was used. The technique used
for impacted bone allografts has been described in detail previously [2,
3]. First, segmental defects were closed with wire meshes after the
removal of scar tissue, cement, and fibrous interface. Next, deep
frozen bone graft chips of the VUmc bone bank (cancellous, diameter
of approximately 8 mm) were inserted and impacted.
Postoperative Management
Postoperative management included systemic antibiotics during the
first 24 h, followed by anticoagulation therapy for 3 months. Mobili-
zation of patients started with bed exercises on the first postoperative
day up to a period of 3 weeks, followed by partial mobilization with
limited weight bearing on the operated side. Patients were then seen in
the outpatient clinic at 6 weeks, 3 months, 6 months, and 1 year after
surgery. Routine x-rays were performed at regular intervals after
surgery and compared with previous films for signs of bone ingrowth,
trabecularization, cortical remodeling, and migration. (Fig. 1a)
Data Acquisition
Dynamic H2
15O and 18F− scanswere performed using an ECATExact
HR+ scanner (Siemens/CTI, Knoxville, USA), which records 63
Fig. 1. a Postoperative AP radiograph showing a patient
treated with hip revision arthroplasty using impaction grafting
and reconstruction of segmental defects of the right hip. b
Coronal 18F− PET image of the same patient as illustrated in
a. Increased uptake is present in the area surrounding the
femoral and acetabular prosthesis.
O.P.P. Temmerman, et al.: Bone Metabolism after Total Hip Revision Surgery 289
continuous planes in an axial field of view of 15.5 cm. First, a 10-min
transmission scan of the hip region was performed, using three rotating
68Ge sources. After bolus injection (15 s; 10 ml/min) using an
automated injector (Medrad, Pittsburgh, USA) of 1,000 MBq H2
15O
in an antecubital vein, a dynamic emission scan (in 2-D mode) was
started. The scanning sequence consisted of the following frames:
12×5, 12×10, 6×20, and 10×30 s (total=10 min). During the H2
15O
scan, arterial blood was withdrawn continuously (5 ml/min) from the
distal radial artery using an online blood sampler (Veenstra, Joure,
The Netherlands). 18F− PET acquisition started 10 min after the
H2
15O scan to allow for decay of H2
15O activity. A 60-min dynamic
emission scan was started after i.v. injection of 100 MBq 18F− using
the following scanning sequence: 6×5, 6×10, 3×20, 5×30, 5×60,
8×150, and 6×300 s. To acquire the input function, i.e., the time
course of H2
15O and 18F− in arterial plasma, arterial blood was
withdrawn continuously from the radial artery at a rate of 5 ml/min
during the first 10 min and at a rate of 2.5 ml/min thereafter. At set
times, continuous withdrawal was interrupted to collect manual
samples. For these samples, both whole blood and plasma concen-
trations were measured using a cross-calibrated well-counter.
Data Analysis
Dynamic scan data were corrected for decay, dead time, scatter,
randoms, and (measured) photon attenuation and reconstructed as
128×128 matrices using filtered back projection with a Hanning filter
(cut-off 0.5 cycles/pixel). To enhance the anatomical orientation and
to facilitate correct positioning of the regions of interest (ROI), the last
ten frames of the [18F−]fluoride scan were summed (20–60 min p.i.)
(Fig. 1b). ROI were drawn around the endoprosthesis in an axial
plane. These ROI were then grouped to form one single ROI, which
was copied, mirrored, and positioned onto the contralateral femur or
acetabulum at the same level on both [18F–]fluoride and H2
15O
dynamic scans. In a similar fashion, ROI were defined around the
allogeneic cancellous grafts (within the acetabulum and femoral
cavity) of the acetabulum or femur of the operated side. Next, both
ROI were subtracted from each other, resulting in tissue time–
activity curves of allogeneic cancellous grafts and cortical bone.
Blood flow was estimated by fitting H2
15O tissue time–activity
curves to a single tissue compartment model using standard nonlinear
regression techniques [11, 12]. These time–activity curves were fitted
both with and without including an arterial blood volume (Va)
component. In these fits, the delay and dispersion of the online input
function were individually fixed to the values obtained from a fit of
the total count rate of the scanner, which included these parameters
[11].
Fluoride kinetics were estimated by fitting tissue time–activity
curves to a two-tissue compartment model. The two-tissue compart-
ments consisted of the extravascular compartment and bone
mineral. Four different rate constants (k1, k2, k3, k4) describe the
exchange of fluoride between plasma and tissue and between the
two-tissue compartments. The net clearance of fluoride from
plasma to bone mineral is described by the parameter Ki. Ki is
calculated with the following equation: Ki ¼ k1  k3= k2 þ k3ð Þ.
The presence of an arterial blood volume (Va) and the fourth
kinetic parameter (k4) in the fluoride model was evaluated
using standard criteria [13, 14].
Absolute values of blood flow and bone metabolism (Ki) at the
operated side were compared to those of the contralateral hip region
and to the preoperative values using the nonparametric Friedman
test or Wilcoxon matched pairs test. A p value of G0.05 was
considered to be significant. Results are expressed as mean values
with their standard deviation. PET parameters Ki and blood flow
were correlated using linear regression.
Results
In five out of 30 scanning sequences, the H2
15O scan could
not be performed because of problems related to the
production of H2
15O and, in one occasion, to hardware
failure of the PET scanner. No artifacts because of the
implant materials were observed in the reconstructed images.
Clinical Outcome
Clinical outcome was good for all patients. In all cases,
routine x-rays showed signs of bone ingrowth, trabeculari-
zation, and cortical remodeling. All patients were mobilized
using a standardized protocol and visited our outpatient
clinic as described previously.
Blood Flow
In the primary group (Fig. 2a), preoperative mean bone blood
flow was 0.082±0.050 ml·min−1·ml−1 in the hip region where
a hip prosthesis had to be inserted and 0.060±
0.033 ml·min−1·ml−1 in the contralateral hip (p=0.22; group
A; scan 1i vs. scan 1c). Two weeks after surgery, blood flow
was 0.090±0.010 ml·min−1·ml−1 around the prosthesis and
0.054±0.014 ml·min−1·ml−1 at the contralateral side (p=0.11;
group A; scan 2i vs. scan 2c). Three months after surgery,
bone blood flow was significantly higher around the prosthesis
with 0.089±0.038 ml·min−1·ml−1 compared to 0.048±
0.010 ml·min−1·ml−1 at the contralateral side (p=0.043; group
A; scan 3i vs. scan 3c). In the group of patients undergoing a
revision (Fig. 2b), bone blood flow around the prosthesis was
twofold to threefold higher compared to the contralateral side,
but differences did not reach significance (group B; scan 2i
vs. scan 2c and scan 3c).
Patients undergoing a revision had a higher bone blood flow
at the prosthetic side of 0.183 ml·min−1·ml−1 compared to the
primary group who had a mean blood flow of 0.090ml·min−1·ml−1
(p=0.05) 2 weeks postoperatively (group A vs. B; scan 2i). At
the two other time points (preoperatively and 3 months
postoperatively), bone blood flow was not significantly
different between primary and revision groups.
Bone Metabolism
Only in ten out of 104 comparisons the four-parameter
model was preferred for the description of fluoride kinetics,
according to standard criteria [13, 14]. Therefore, a three-
parameter model (i.e., k4 was set to 0) was used for the
analysis of fluoride kinetics. In Fig. 3, a summary of the Ki
values is presented as measured in both operated and
nonoperated hips of patients undergoing primary total hip
arthroplasty or hip revision arthroplasty.
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In patients undergoing a primary total hip prosthesis
(Fig. 3a), the periprostheticKi increased nonsignificantly from
0.0046±0.0023 to 0.015±0.010 min−1 at 2 weeks (p=0.08)
and significantly to 0.020±0.010 min−1 at 12 weeks (p=
0.043; group A; scan 1i, 2i, and 3i). In patients undergoing a
primary total hip prosthesis implantation, bone metabolism in
the contralateral hip region increased from 0.0059±0.0051 to
0.010±0.0035 min−1 at 2 weeks (p=0.08) and to 0.010±
0.0036 min−1 at 12 weeks (p=0.043; group A; scan1c vs. 2c
vs. 3c). In patients undergoing hip revision surgery (Fig. 3b),
Ki increased from 0.030±0.024min
−1 preoperatively to 0.046±
0.024 min−1 at 2 weeks after surgery (p=0.18; group B;
scan1c vs. 2c). At 12 weeks after revision surgery, the Ki
returned to 0.028±0.015 min−1, not different from the
preoperative Ki (p=0.59; group B; scan1c vs. 3c).
Bone metabolism (Ki) in the periprosthetic region in
patients undergoing revision was threefold higher 2 weeks
postoperatively compared to the primary hip group (0.046±
0.024 vs. 0.015±0.010 min−1, respectively; p=0.036; group
A vs. group B; scan 2c). Hence, aside from the operation
effects, impaction bone grafting induced additional fluoride
incorporation within 2 weeks postoperatively compared to
patients who received a hip prosthesis without bone grafting.
However, at 3 months, a nonsignificant difference in
bone metabolism was seen between patients with
(Ki ¼ 0:028 0:015) and without (Ki ¼ 0:020 0:010) bone
grafts (p=0.556; group A vs. group B; scan 3c).
Correlation between Fluoride Metabolism
and Bone Blood Flow
Linear regression analysis showed a significant correlation
between Ki and bone blood flow in the same region with a
correlation coefficient of 0.72 (pG0.001), as shown in Fig. 4.
Discussion
We found a significant increase in periprosthetic bone
metabolism in patients in whom allogeneic bone grafts were
used compared to patients where no bone grafts were used.
Hence, the addition of bone graft induces higher osteoblastic
activity than surgery or surgical trauma to bone alone.
Furthermore, increased uptake of [18F−]fluoride was found in
the contralateral hip of patients receiving a primary hip
prosthesis, indicating increased bone formation at the
nonoperated side. Periprosthetic bone blood flow was
increased at 2 weeks and 3 months after surgery. Finally,
Ki (Primary prosthesis) 
0
0,01
0,02
0,03
0,04
Scan number 
K
i (
 m
in
-1
) 
K
i (
 m
in
-1
) 
Ki (Revised prosthesis) 
0
0,04
0,08
Sc
an
 1i
Sc
an
 1c
Sc
an
 2i
Sc
an
 2c
Sc
an
 3
i
Sc
an
 3
c
Sc
an
 1i
Sc
an
 1c
Sc
an
 2i
Sc
an
 2c
Sc
an
 3
i
Sc
an
 3
c
Scan number
a
b
Fig. 3. aKi of
18F− and 95% confidence intervals in the
group of patients undergoing primary hip arthroplasty pre-
operatively (scan 1) and 2 weeks (scan 2) and 12 weeks (scan
3) after surgery. i ipsilateral, c contralateral. bKi of
18F− and
95% confidence intervals in the group of patients undergoing
hip revision arthroplasty preoperatively (scan 1) and 2 weeks
(scan 2) and 12 weeks (scan 3) after surgery. i ipsilateral, c
contralateral.
Blood flow (primary prosthesis)
0
0,05
0,1
0,15
Sc
an
 1
i
Sc
an
 1
c
Sc
an
 2
i
Sc
an
 2
c
Sc
an
 3
i
Sc
an
 3
c
Sc
an
 1
i
Sc
an
 1
c
Sc
an
 2
i
Sc
an
 2
c
Sc
an
 3
i
Sc
an
 3
c
Scan number
Scan number
 
B
lo
o
d
 f
lo
w
 (
m
l m
in
-1
 m
l-1
) 
B
lo
o
d
 f
lo
w
 (
m
l m
in
-1
 m
l-1
) Blood flow (Revised prosthesis)
0
0,05
0,1
0,15
0,2
a
b
Fig. 2. a Bone blood flow and 95% confidence intervals in
the group of patients undergoing primary hip arthroplasty
preoperatively (scan 1) and 2 weeks (scan 2) and 12 weeks
(scan 3) after surgery. i ipsilateral, c contralateral. b Bone
blood flow and 95% confidence intervals in the group of
patients undergoing hip revision arthroplasty preoperatively
(scan 1) and 2 weeks (scan 2) and 12 weeks (scan 3) after
surgery. i ipsilateral, c contralateral.
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periprosthetic [18F−]fluoride uptake was correlated with bone
blood flow, suggesting that bone formation and bone blood
flow are coupled. Unfortunately, in five out of 30 scanning
sequences, the H2
15O scan could not be performed.
Furthermore, the limited number of patients may be an
important factor for some of the nonsignificant findings.
[18F−]fluoride has been applied for the evaluation of bone
metabolism and neoplastic diseases [6, 8, 15–22]. In the
present study, this technique was applied to evaluate bone
metabolism of morselized allografts in patients treated with
total hip revision arthroplasty and primary total hip arthro-
plasties. Patients receiving allogeneic bone grafts had higher
[18F−]fluoride influx compared to patients undergoing
implantation of a total hip prostheses. In an earlier study
where a simplified Patlak analysis was used for the
calculation of [18F−] fluoride kinetics, a threefold to fourfold
higher [18F−]fluoride uptake was found 1 week after surgery
compared to the contralateral bone in the same patient [8].
As the main interest of the present study was bone formation
and effects of allogeneic bone grafts, a control group
undergoing primary total hip implantation was used to
account for local surgical trauma. Two weeks after surgery,
patients receiving bone grafts had a threefold higher [18F−]
fluoride uptake compared to patients receiving total hip
implantation. Hence, these results suggest that allogeneic
bone grafts induce rapid new bone formation independent of
local surgical trauma. In the present analysis, a two-tissue
compartmental model together with nonlinear regression was
used to calculate the net rate of uptake Ki of
18F−. This was
based on a study of Piert et al. [23] who demonstrated that
the Ki obtained from nonlinear regression has been shown to
correlate better with histomorphometric parameters of bone
formation than the Patlak-derived Ki. Increased [
18F−]
fluoride uptake was found within 2 weeks after surgery.
Whether this rapid increased uptake of [18F−]fluoride is the
result of new bone formation from the patient’s own
osteoblasts or from osteoblasts originating from the allograft
remains uncertain. It is interesting to note that an earlier
study has shown new bone formation and osteogenic activity
from bone cells in bone allografts [24]. The osteoinductive
potential is, however, more likely to result from matrix-
associated bone morphogenetic proteins. It is interesting to
note that also the contralateral femur of patients receiving a
primary hip arthroplasty showed an increased level of bone
formation. This increase of bone formation at the contralat-
eral side could be induced by increased exercise or walking
by the patients after surgery compared to the exercise level
before surgery. On the other hand, circulating mediators
influencing bone formation may also have contributed to the
rise of 18F− uptake in the contralateral hip.
Compared to the contralateral femur, a doubling of blood
flow within 2 weeks after surgery was found. In addition, at
3 months, increased bone blood flow values were found
compared to the contralateral femur. These findings are
similar to findings in earlier reports and are most likely the
result of surgical trauma, subsequent neovascularization, and
proliferation of bone grafts [8, 25, 26]. When comparing
blood flow between patients treated with a primary and
revision arthroplasties 2 weeks postoperatively, however, a
clear trend of increased flow in the group with revision
arthroplasty was seen. Lack of statistical significance may be
explained by the relatively low number of patients. This
marked increase in blood flow at 2 weeks after the use of
bone grafts may suggest that morselized bone allografts have
an osteogenic effect causing an increase in neovasculariza-
tion and subsequent osteoblast activity. This osteogenic
effect of allografts has previously been suggested [8], but
without verification using a control group (primary arthro-
plasty). Three months after surgery, blood flow stabilized at
approximately 150% of the preoperative flow value. Blood
flow was correlated to some extent with Ki, representing the
net [18F−]fluoride uptake. Approximately 50% of Ki vari-
ability could be explained by the variability in bone blood
flow. In an earlier study, a similar result was found, showing
a coupling of porcine blood flow and metabolism in high-
turnover bone disease [23]. Other factors, such as bone
morphogenetic proteins, may also have an effect on the
alterations in bone metabolism, as 50% of the variation in
bone metabolism could not be explained by variation in bone
blood flow [19].
Conclusion
Increased bone blood flow indicates early neovascularization
within 2 weeks after implantation of allogeneic bone grafts.
Allogeneic bone grafts induce a higher rate of local
periprosthetic bone formation compared to periprosthetic
bone formation after a primary total hip placement. PET
provides a way to assess the metabolic activity in bone grafts
and thus may provide an important tool for clinicians to
assess in vivo bone graft behavior, which relates to clinical
outcome. However, because of the limited number of
patients currently included, further studies are needed to
assess the clinical value of PET imaging in patients treated
with revision hip surgery.
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